One of the ironies of the situation we had find ourselves in today is that many of us are having to work from home in our ‘home offices’ whilst trying to accelerate the development of urgently required diagnostics and therapeutics. Under the most optimal conditions, such R&D activity takes vast resources and time but now that those same teams have had to operate in disparate locations, many away from the familiar laboratory environment, it all becomes even more challenging!
